Omalizumab is prescribed for:
- Moderate-to-severe allergic asthma
- Chronic idiopathic urticaria (hives)
- Chronic rhinosinusitis with nasal polyps
- Food allergies (IgE-mediated)
- Respiratory and immunologic conditions
Generic Name: Omalizumab
Brand Names: Xolair
Omalizumab is an anti-IgE biologic for allergic asthma, chronic urticaria, nasal polyps, and food allergies.
Omalizumab is prescribed for:
Common side effects:
Serious side effects:
Omalizumab is a monoclonal antibody that binds to IgE, preventing allergic responses.
Carries a boxed warning for anaphylaxis. Must be administered in healthcare settings with observation period.
Recently approved for IgE-mediated food allergies to reduce risk of allergic reactions to accidental exposure (not a cure).
Learn more at MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Asthma, a chronic lung disease, causes airway inflammation and narrowing, resulting in wheezing, coughing, and shortness of breath, triggered by allergens, irritants, infections, or stress.
Sinusitis involves sinus inflammation and blockage due to infections, allergies, or structural issues, causing facial pain, pressure, and congestion, often following colds or triggered by allergens.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Omalizumab? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.